Are the ACC/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel

Canadian Journal of Cardiology

Volumn 30, Issue 4, 2014, Pages 377-380

  Anderson, Todd J ^a   Grégoire, Jean ^b   Hegele, Robert A ^c   Couture, Patrick ^d   Mancini, G B John ^e   McPherson, Ruth ^f   Francis, Gordon A ^e   Poirier, Paul ^g   Lau, David C ^a   Grover, Steven ^h   Genest, Jacques ^h   Carpentier, André C ⁱ   Dufour, Robert ^j   Gupta, Milan ^k   Ward, Richard ^l   Leiter, Lawrence A ^m   Lonn, Eva ⁿ   Ng, Dominic S ^m   Pearson, Glen J ^o   Yates, Gillian M ^p   Stone, James A ^a   Ur, Ehud ^e   more..

^a UNIVERSITY OF CALGARY   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

ⁱ CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^j CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^k MCMASTER UNIVERSITY   (Canada)

^l UNIVERSITY OF CALGARY   (Canada)

^m ST MICHAEL'S HOSPITAL   (Canada)

ⁿ MCMASTER UNIVERSITY   (Canada)

^o UNIVERSITY OF ALBERTA   (Canada)

^p QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; EDITORIAL; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL SOCIETY; PHYSICIAN; PRACTICE GUIDELINE; RISK ASSESSMENT;

ATHEROSCLEROSIS; CANADA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS; DYSLIPIDEMIAS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SOCIETIES, MEDICAL; STROKE; UNITED STATES;

EID: 84897098204     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.01.009     Document Type: Editorial

References (9)

1. Stone NJ, Robinson J, Lichtenstein AH, etal. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines [epub ahead of print]. JAm Coll Cardiol. Accessed November 07, 2013. doi:10.1016/j.jacc.2013.
2. Anderson T.J., Gregoire J., Hegele R.A., et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2013, 29:151-167.
3. Baigent C., Landray M.J., Reith C., et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet 2011, 377:2181-2192.
4. Goff D.C., Lloyd-Jones D.M., Bennett G., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines [epub ahead of print]. J Am Coll Cardiol 2013, http://dx.doi.org/10.1016/j.jacc.2013.11.005. Accessed November 07, 2013.
5. D'Agostino R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 2008, 117:743-753.
6. Ridker P.M., Cook N.R. Statins: new American guidelines for prevention of cardiovascular disease. Lancet 2013, 382:1762-1765.
7. Mihaylova B., Emberson J., et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012, 380:581-590. Cholesterol Treatment Trialists' (CTT) Collaborators.
8. Reiner Z., Catapano A.L., et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011, 32:1769-1818. European Association for Cardiovascular Prevention and Rehabilitation.
9. Tobe S.W., Stone J.A., Brouwers M., et al. Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE initiative. CMAJ 2011, 183:E1135-E1150.